ADAPTABLE Research Summary
Investigator: Drs. Matthew T. Roe, MD, MHS, Duke Clinical Research Institute
Purpose: ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) is a three-year pragmatic clinical trial that will compare the effectiveness of two different daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease. Pragmatic trials are designed to reflect “real-world” medical care by recruiting broad populations of patients, embedding the trial into the usual healthcare setting, and leveraging data from health systems to produce results that can be readily used to improve patient care.
Goal: To study which aspirin dose is best to protect patients with heart disease
About this study:
Results of this study will help patients and their caregivers answer questions like:
How to participate:
The ADAPTABLE study will enroll and follow as many as 20,000 patients with heart disease. Eligible participants in ADAPTABLE will be identified from large health systems that are part of PCORnet’s Clinical Data Research Networks (CDRNs).
Click here to learn more.